|
1) Mukai K, Matsuoka K, Taya C, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity. 2005; 23: 191-202
|
|
|
|
2) Obata K, Mukai K, Tsujimura Y, et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood. 2007; 110: 913-20
|
|
|
|
|
|
3) Tsujimura Y, Obata K, Mukai K, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity. 2008; 28: 581-9
|
|
|
|
|
|
4) Sokol CL, Barton GM, Farr AG, et al. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol. 2008; 9: 310-8
|
|
|
|
|
|
5) Denzel A, Maus UA, Gomez MR, et al. Basophils enhance immunological memory responses. Nat Immunol. 2008; 9: 733-42
|
|
|
|
|
|
6) Richerson HB, Dvorak HF, Leskowitz S. Cutaneous basophil hypersensitivity. I. A new look at the Jones-Mote reaction, general characteristics. J Exp Med. 1970; 132: 546-57
|
|
|
|
|
|
7) Katz SI. Recruitment of basophils in delayed hypersensitivity reactions. J Invest Dermatol. 1978; 71: 70-5
|
|
|
|
|
|
8) Prussin C, Metcalfe DD. 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2003; 111: S486-94
|
|
|
|
|
|
9) Galli SJ. Mast cells and basophils. Curr Opin Hematol. 2000; 7: 32-9
|
|
|
|
|
|
10) Seder RA, Paul WE, Dvorak AM, et al. Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci U S A. 1991; 88: 2835-9
|
|
|
|
|
|
11) Schroeder JT, MacGlashan DW Jr, Lichtenstein LM. Human basophils: mediator release and cytokine production. Adv Immunol. 2001; 77: 93-122
|
|
|
|
|
|
12) Kepley CL, McFeeley PJ, Oliver JM, et al. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Respir Crit Care Med. 2001; 164: 1053-8
|
|
|
|
|
|
13) Macfarlane AJ, Kon OM, Smith SJ, et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol. 2000; 105: 99-107
|
|
|
|
|
|
14) Sato E, Hirahara K, Wada Y, et al. Chronic inflammation of the skin can be induced in IgE transgenic mice by means of a single challenge of multivalent antigen. J Allergy Clin Immunol. 2003; 111: 143-8
|
|
|
|
|
|
15) Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117: 391-7
|
|
|
|
|
|
16) Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007; 120: S2-24
|
|
|
|
|
|
17) Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med. 1991; 324: 1785-90
|
|
|
|
|
|
18) Galli SJ. Pathogenesis and management of anaphylaxis: current status and future challenges. J Allergy Clin Immunol. 2005; 115: 571-4
|
|
|
|
|
|
19) Kraft S, Kinet JP. New developments in Fc epsilon RI regulation, function and inhibition. Nat Rev Immunol. 2007; 7: 365-78
|
|
|
|
|
|
20) Winbery SL, Lieberman PL. Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol. 2002; 17: 287-317
|
|
|
|
|
|
21) Miyajima I, Dombrowicz D, Martin TR, et al. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gamma RIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest. 1997; 99: 901-14
|
|
|
|
|
|
22) Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. 2008; 358: 28-35
|
|
|
|
|
|
23) Mowen KA, Glimcher LH. Signaling pathways in Th2 development. Immunol Rev. 2004; 202: 203-22
|
|
|
|
|